Option chain shows key data for ISHARES PLC RESOURCES NL by IShares Plc.'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for ISHARES PLC RESOURCES NL by IShares Plc..

ISHARES PLC RESOURCES NL by IShares Plc. (OTC:IHRPF) Stock, Option Chain

ISHARES PLC RESOURCES NL by IShares Plc.

WIIM

SIGA

SIGA Technologies shares are trading higher after the company announced TEPOXX was approved in Japan for the treatment of orthopoxviruses.

VERI

Veritone shares are trading lower after the company announced the pricing of a $20.3 million registered direct offering.

Biotech

General

PHIO

Phio Pharmaceuticals Announces Publication Of Research Entitled 'Self-delivering RNAi Compounds for Reduction of Hyperpigmentation' In Dec. 2024 Issue Of Clinical, Cosmetic and Investigational Dermatology

SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) has faced recent downgrades from <a href="https://www.benzinga.com/analyst-ratings/upgrades/24/12/42407670/sofi-technologies-shares-fall-after-bofa-downgrade-over-valuation-concerns">analysts</a> citing concerns over the company&#8217;s high valuation. However, technical analysis, particularly moving averages, suggests potential support for the stock. 
What Happened: SoFi was downgraded to &#8216;underperform&#8217; by Keefe, Bruyette, and Woods (KBW), despite a recent rally driven by investor optimism and lower interest rates. While KBW slightly increased its price target, it expressed concerns about SOFI&#8217;s lofty valuation, deeming its long-term earnings potential insufficient to justify the current stock price.
The brokerage emphasized the challenges of achieving ambitious earnings targets, citing the need for significant revenue growth and margin improvement. KBW concluded that the current risk-reward profile for SOFI investors leans heavily toward potential losses.
According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, the stock was nearly three times more expensive than its peers. The forward price-to-earnings for SoFi was 76.923, whereas the average of its peers stood at 26.384.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Stocks</td>
<td>Market Cap</td>
<td>Forward P/E</td>
</tr>
<tr>
<td>American Express (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axp#NYSE">AXP</a>)</td>
<td>209.453B</td>
<td>19.531</td>
</tr>
<tr>
<td>Capital One Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>)</td>
<td>67.880B</td>
<td>11.696</td>
</tr>
<tr>
<td>Discover Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>)</td>
<td>43.322B</td>
<td>14.065</td>
</tr>
<tr>
<td>Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>)</td>
<td>25.327B</td>
<td>9.709</td>
</tr>
<tr>
<td>SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)</td>
<td>16.711B</td>
<td>76.923</td>
</tr>
<tr>
<td></td>
<td></td>
<td>Average: 26.3848</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a></figcaption></figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/42754775/dollar-strength-to-be-driven-by-trumps-deregulation-tariff-and-tax-policies-in-2025-after-a-strong-2024">Dollar Strength To Be Driven By Trump&#8217;s Deregulation, Tariff And Tax Policies In 2025 After A Strong 2024 </a>
Why It Matters: In December, BofA Securities downgraded SoFi, citing overvaluation. They believed SoFi&#8217;s current stock price was ahead of its financial performance, trading at a significant premium to its peers.
Conversely, Jefferies maintained its &#8220;Buy&#8221; rating on SoFi and increased its price target, expressing optimism about the company&#8217;s future
From a technical perspective, the analysis of daily moving averages shows strong support for the SoFi Tech stock.
SoFi&#8217;s shares closed at $15.4 apiece on Tuesday, this was above its 50, and 200-day simple moving averages, suggesting a largely bullish trend. The 20-day moving average price was $15.86 apiece. 
These simple moving averages represent the average price of the security over the specified number of days. While 50 and 200-day averages represent longer-term prices, the eight and 20-day moving averages are for shorter periods. 
On the other hand, the relative strength index of 50.75 suggested that the stock is in the neutral zone.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock-1024x576.png" alt="" class="wp-image-714438" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024249/SOFI-stock.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Price Action: The company shares rose 59.59% in 2024, outperforming the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which rose by 26.99%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
According to <a href="https://www.benzinga.com">Benzinga</a>, SoFi has a consensus price target of $9.98 per share based on the ratings of 26 <a href="https://www.benzinga.com/quote/SOFI/analyst-ratings">analysts</a>. The highest price target out of all the analysts tracked by Benzinga is $16 apiece issued by JPMorgan as of Dec. 2, 2024. The lowest target price is $3 per share issued by Wedbush on April 30, 2024.
The average price target of $13.67 apiece between Morgan Stanley, B of A Securities, and JPMorgan implies an 11.14% downside for SoFi.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/SOFI/analyst-ratings"><img loading="lazy" decoding="async" width="942" height="349" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024537/SOFI-ANR.png" alt="" class="wp-image-714441" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024537/SOFI-ANR.png 942w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024537/SOFI-ANR-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02024537/SOFI-ANR-768x285.png 768w" sizes="(max-width: 942px) 100vw, 942px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/42754939/sp-500-scaled-a-record-57-all-time-highs-in-2024-heres-what-analysts-think-is-in-store-in-2025">S&amp;P 500 Scaled A Record 57 All-Time Highs In 2024: Here&#8217;s What Analysts Think Is In Store This Year </a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Equities

Market Summary

Broad U.S. Equity ETFs

Downgrades

Price Target

Technicals

Markets

Analyst Ratings

Trading Ideas

ETFs

SOFI

SoFi Tech Downgraded Over Valuation Concerns: Stock Priced Three Times Its Peers

The allowed patent is directed, among others to be used as primary amine aminoindan compound to regulate binge behavior. This includes primary amine aminoindan compounds beyond 5-methoxy-2-aminoindan (MEAI), the Company's innovative psychedelic molecule.

News

Health Care

CMND

Clearmind Medicine Receives Patent Approval From The Macau International Intellectual Property Office For Binge Behavior Treatment

Under the terms of the framework agreement, BitFuFu has the flexibility to place orders in batches over a two-year period. The machines will be available for BitFuFu's self-mining operations as well as to provide mining services to customers including, miner resales, cloud mining, and miner hosting services depending on market conditions and BitFuFu's evolving miner capacity requirements.

FUFU

BitFuFu Recently Signs Two-year Framework Agreement With BITMAIN To Purchase Up To 80,000 S-series Miners

Stephens &amp; Co. analyst Sudan Loganathan reiterates Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) with a Overweight and maintains $140 price target.

Reiteration

BPMC

Stephens & Co. Reiterates Overweight on Blueprint Medicines, Maintains $140 Price Target

Assuming the motion is granted, Sable intends to cooperate with the government to facilitate an expeditious review and that the government's prior extensions to resume operations were both appropriate and authorized. Moreover, under the government's proposed remand, Sable's operations on the Santa Ynez Unit remain unaffected. In the event that any non-governmental third party attempts to unlawfully interfere with Sable from restarting the Santa Ynez Unit, which contains net estimated contingent resources currently valued at over $10 billion, Sable is prepared to vigorously pursue all available legal remedies.&nbsp;

Legal

Sable Offshore Provided An Update On The Previously Disclosed Center For Biological Diversity Et Al. V. Debra Haaland Et Al. Lawsuit. In December, The U.S. Department Of Justice Filed A Motion To Remand Without Vacatur The Haaland Lawsuit To BSEE So That BSEE Could Reconsider Its 2023 Decision Approving An Extension To Resume Operations On The Leases For The Santa Ynez Unit

U.S. stocks settled lower on Tuesday, with the Nasdaq Composite falling around 175 points during the session.
Although major indices settled lower on the final trading session of the year, but they recorded gains in 2024. The S&amp;P 500 surged 23.31% in 2024, after recording a gain of 24.2% during 2023. Meanwhile, the Dow jumped 12.88% last year, while the Nasdaq outperformed with a rally of 28.64%.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Andres Sheppard
<ul>
<li>Analyst Firm: Cantor Fitzgerald</li>
<li>Ratings Accuracy: 88%</li>
<li>Latest Rating: Maintained an Overweight rating on Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) and raised the price target from $10 to $13 on Dec. 18. This analyst sees around 30% upside in the stock.</li>
<li>Recent News: On Dec. 12, Archer announced a partnership with Anduril to develop hybrid VTOL military aircraft and reported raising an additional $430 million in equity capital.</li>
</ul>
Analyst: Jay McCanless
<ul>
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Reiterated a Neutral rating on Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) with a price target of $164 on Dec. 19. This analyst sees around 20% upside in the stock.</li>
<li>Recent News: On Dec. 18, Lennar reported worse-than-expected fourth-quarter financial results.</li>
</ul>
Analyst: Sumeet Mody 
<ul>
<li>Analyst Firm: Piper Sandler</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained a Neutral rating on Enfusion, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>) and raised the price target from $10 to $11.5 on Dec. 23. This analyst sees around 12% upside in the stock.</li>
<li>Recent News: On Nov. 4, Enfusion reported worse-than-expected third-quarter financial results.</li>
</ul>
Analyst: Justin Post
<ul>
<li>Analyst Firm: B of A Securities</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained a Buy rating on Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a price target of $210 on Dec. 23. This analyst sees around 10% surge in the stock.</li>
<li>Recent News: At a strategy meeting featuring Alphabet executives, CEO Sundar Pichai addressed key 2025 topics, including artificial intelligence, competition and regulatory pressure.</li>
</ul>
Analyst: Aaron Rakers
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Overweight rating on Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) and cut the price target from $175 to $140 on Dec. 19. This analyst sees around 65% upside in the stock.</li>
<li>Recent News: On Dec. 18, Micron reported first-quarter revenue of $8.71 billion, missing the consensus estimate of $8.72 billion.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42740135/how-to-earn-500-a-month-from-alphabet-stock">How To Earn $500 A Month From Alphabet Stock</a></li>
</ul>

Pre-Market Outlook

ACHR

ENFN

GOOGL

This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">AGNC Investment Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>)</h3>
<ul>
<li>Dividend Yield: 15.64%</li>
<li>JP Morgan analyst Richard Shane maintained an Overweight rating and cut the price target from $10 to $9.5 on Dec. 9. This analyst has an accuracy rate of 68%.</li>
<li>Wells Fargo analyst Donald Fandetti upgraded the stock from Equal-Weight to Overweight and raised the price target from $10 to $12 on Sept. 20. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On Dec. 11, AGNC Investment declared monthly common stock dividend of 12 cents per common share for December 2024.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest AGNC news. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="907" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074211/image-4.png" alt="" class="wp-image-715015" style="width:579px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074211/image-4.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074211/image-4-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074211/image-4-768x712.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></figure>
<h3 class="wp-block-heading">Two Harbors Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>)</h3>
<ul>
<li>Dividend Yield: 15.22%</li>
<li>RBC Capital analyst Kenneth Lee maintained a Sector Perform rating and cut the price target from $14 to $12 on Nov. 1. This analyst has an accuracy rate of 69%.</li>
<li>JP Morgan analyst Richard Shane maintained a Neutral rating and cut the price target from $13.5 to $11.5 on Oct. 30. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On Nov. 12, TWO announced the appointment of Travis Swenson as Chief Financial Officer.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest TWO news </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="912" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074236/image-5.png" alt="" class="wp-image-715016" style="width:686px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074236/image-5.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074236/image-5-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074236/image-5-768x717.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></figure>
<h3 class="wp-block-heading">Horizon Technology Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>)</h3>
<ul>
<li>Dividend Yield: 14.68%</li>
<li>Compass Point analyst Casey Alexander upgraded the stock from Sell to Neutral with a price target of $8.25 on Dec. 17. This analyst has an accuracy rate of 68%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Paul Johnson maintained an Underperform rating and lowered the price target from $9.5 to $9 on Aug. 1. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Oct. 29, Horizon Tech Finance posted weaker-than-expected quarterly results.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in HRZN stock. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="913" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074324/image-2-2.png" alt="" class="wp-image-715020" style="width:579px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074324/image-2-2.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074324/image-2-2-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02074324/image-2-2-768x707.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42740135/how-to-earn-500-a-month-from-alphabet-stock">How To Earn $500 A Month From Alphabet Stock</a></li>
</ul>

Dividends

AGNC

HRZN

Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 14% Dividend Yields

Automotive research firm&nbsp;S&amp;P Global Mobility&nbsp;expects 15.1 million units of battery electric vehicles to be sold in 2025, marking a growth of 30% from 2024 levels. 
What Happened: S&amp;P Global Mobility expects battery electric vehicle sales to account for an estimated 16.7% of global light vehicle sales in 2025, up from 13.2% market share in 2024.
While battery electric vehicles will account for <a href="https://www.benzinga.com/news/global/24/12/42737888/tesla-rival-xpeng-to-hire-over-6000-workers-in-2025-expecting-increased-competition-report">29.7% of light vehicle sales in China</a>, in the U.S. it will be only 11.2%, the firm said. However, BEV market share will increase across Europe, the U.S., China, and India, it added. 
The firm now expects 89.5 million new vehicles to be sold globally next year, marking a growth of 1.7% year-on-year.
&#8220;2025 is shaping up to be ultra-challenging for the auto industry, as key regional demand factors limit demand potential and the new US administration adds fresh uncertainty from day one,&#8221; said&nbsp;Colin Couchman, executive director of global light vehicle forecasting for S&amp;P Global Mobility, in a statement. &#8220;A key concern is how &#8216;natural&#8217; EV demand fares as governments rethink policy support, especially incentives and subsidies, industrial policy, tariffs, and fast-evolving OEM target setting.&#8221;
Why It Matters: Beyond 2025, the firm sees many factors <a href="https://www.benzinga.com/24/12/42600762/where-ev-stocks-are-going-in-2025">impacting the EV transition</a>, including charging infrastructure, battery supply chains, tariff trade barriers, and more. There is also less certainty around President-elect Donald Trump&#8217;s support for electric vehicles, the firm noted.
In the U.S. alone, S&amp;P expects vehicle sales volume to touch 16.2 million units in 2025, marking a 1.2% growth from the 16 million projected for 2024. 
&#8220;New vehicle affordability issues that coalesced to constrain auto demand levels for much of 2024 will not be resolved quickly in 2025. Vehicle pricing levels are expected to decline but remain high; interest rates are expected to shift further downwards, but inflation levels are anticipated to remain sticky, and new vehicle inventory should also progress, but careful management is expected too,&#8221; said&nbsp;Chris Hopson, manager of North American light vehicle sales forecasting for S&amp;P Global Mobility.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42758540/us-listed-chinese-ev-startups-clock-delivery-growth-in-december-li-auto-tops-the-chart-mona-m03-spurs-xpeng-nios-onvo-breaches-10000-monthly-delivery-milestone" target="_blank" rel="noreferrer noopener">US-Listed Chinese EV Startups Clock Delivery Growth In December: Li Auto Tops Charts, Mona M03 Spurs XPeng, Nio&#8217;s Onvo Breaches 10,000 Monthly Delivery Milestone</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Battery Electric Vehicle Sales To Surge 30%, Capture 17% of Global Light Vehicle Market By 2025: Report

Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) experienced a 1.44% increase in pre-market trading on Thursday, as per <a href="https://pro.benzinga.com">Benzinga Pro.</a> The rise follows the announcement that the Cybertruck qualifies for a&nbsp;$7,500 electric vehicle <a href="https://www.benzinga.com/25/01/42759653/cybertruck-all-wheel-drive-now-eligible-for-7500-ev-tax-credit">consumer tax&nbsp;credit</a>.
The U.S. government confirmed on&nbsp;its&nbsp;fueleconomy.gov&nbsp;website that customers&nbsp;taking delivery of the Cybertruck&nbsp;this year can receive the tax credit&nbsp;on both the dual motor&nbsp;and single motor variants. Although&nbsp;production of the single-motor variant&nbsp;has not yet begun, it will be eligible for the credit once sales commence.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42740507/reddit-user-asks-how-do-so-many-people-afford-multi-million-dollar-homes-says-even-six-figure-salaries-mean-nothing-in-this-area?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Reddit User Asks, &#8216;How Do So Many People Afford Multi-Million Dollar Homes?&#8217; Says Even Six-Figure Salaries &#8216;Mean Nothing In This Area&#8217;</a>
With the tax credit, the&nbsp;Cybertruck&#8217;s all-wheel variant&#8217;s effective starting price will be $72,490 for qualifying buyers, while the&nbsp;rear-wheel drive single-motor variant will&nbsp;start at $53,490 after deliveries begin. The Cyberbeast premium variant, priced at $99,990, will not qualify due to exceeding the $80,000 price limit.
Currently, all variants of the Model Y, Model 3, and Model X all-wheel drive variants sold in the U.S. are eligible for the $7,500 tax credit.
This follows a recent incident in Las Vegas where <a href="https://www.benzinga.com/tech/25/01/42757901/elon-musk-fireworks-or-explosive-device-caused-fatal-cybertruck-incident-at-las-vegas-trump-hotel-vehicle-was-rented">a Cybertruck caught fire</a> near the Trump International Hotel. CEO Elon Musk addressed the issue on X, stating that the fire was caused by fireworks or a bomb, not a vehicle malfunction.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42739155/elon-musk-changes-his-name-to-kekius-maximus-on-x-sending-to-memecoin-skyrocketing-over-600?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Changes His Name To &#8216;Kekius Maximus&#8217; On X, Sending This Memecoin Skyrocketing Over 600%</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

TSLA

Tesla Shares Rise In Thursday Premarket Despite Recent Cybertruck Explosion Outside Trump's Las Vegas Hotel: Here's Why

The aggregate gross proceeds to the Company from the offering are expected to be approximately $20.3 million, before deducting offering expenses payable by the Company.&nbsp;

Offerings

Veritone Reports Pricing Of Direct Offering Of 8.02M Shares Of Common Stock (Or Pre-funded Warrants) At $2.53 Per Share (Or $2.52 For Each Pre-funded Warrant) To Esousa Group

Stephens &amp; Co. analyst Kyle Joseph reiterates PROG Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRG#NYSE">PRG</a>) with a Overweight and maintains $60 price target.

Stephens & Co. Reiterates Overweight on PROG Holdings, Maintains $60 Price Target

Stephens &amp; Co. analyst John Campbell reiterates CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) with a Overweight and maintains $103 price target.

CSGP

Stephens & Co. Reiterates Overweight on CoStar Gr, Maintains $103 Price Target

Stephens &amp; Co. analyst Andrew Terrell reiterates Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) with a Overweight and maintains $30 price target.

BMRC

Stephens & Co. Reiterates Overweight on Bank of Marin, Maintains $30 Price Target

On Wednesday, Hutchmed (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) entered into two agreements to divest its 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately $608 million (RMB 4.478 billion) in cash to GP Health Service Capital Co., Ltd and Shanghai Pharmaceuticals Holding Co., Ltd.
Hutchmed has been exploring opportunities to monetize the underlying value of SHPL, a non-core, non-<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42754584/hutchmed-announces-us-608-million-divestment-of-non-core-joint-venture" rel="noreferrer noopener">consolidated joint venture</a>.
These transactions would allow Hutchmed to focus on its core business of discovering, developing, and commercializing novel therapies for cancers and immunological diseases, including advancing its next-generation antibody-targeted therapy conjugate programs.
SHPL primarily manufactures, sells, and distributes its own-brand prescription medicines in China, predominantly for cardiovascular diseases.
SHPL is a 50:50 joint venture established between Hutchmed and Shanghai Pharma in 2001.
In 2023, the consolidated net income attributable to Hutchmed from SHPL was $47.4 million. HUTCHMED does not consolidate revenue from SHPL.
Hutchmed plans to invest the proceeds from these transactions to further develop its internal pipeline and advance its core business strategy.
Hutchmed plans to move the first of these antibody-targeted therapy conjugates into clinical trials in the second half of 2025.
Before the transactions, Hutchmed and Shanghai Pharma each hold a 50% equity interest in SHPL. GP Health Service Capital has agreed to acquire a 35% equity interest for approximately $473 million in cash, and Shanghai Pharma will acquire a 10% equity interest for approximately $135 million in cash.
After the transactions, the investors will hold a 60% equity interest in SHPL. Out of its 35%, GP Health Service Capital retains the right to designate a third-party investment fund to acquire up to a 10% equity interest in SHPL.
Hutchmed will retain a 5% equity interest in SHPL after the transactions.
Hutchmed expects to record a gain on disposal of approximately $477 million before taxation.
On Wednesday, Hutchmed announced that the China National Medical Products Administration accepted and granted priority review of the New Drug Application for the combination of Orpathys (savolitinib) and Tagrisso (osimertinib) for locally advanced or metastatic epidermal growth factor receptor mutation-positive non-small cell lung cancer with MET amplification <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42757633/hutchmed-announces-nda-acceptance-in-china-with-priority-review-status-for-orpathys-and-tagrisso-c" rel="noreferrer noopener">after disease progression</a>.
The acceptance also triggers a milestone payment from AstraZeneca plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>).
Price Action: At last check on Wednesday, HCM stock was up 7.98% at $15.56 during the premarket session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42745915/why-is-brain-cancer-focused-kazia-therapeutics-stock-trading-lower-on-tuesday" target="_blank" rel="noreferrer noopener">Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?</a></li>
</ul>

Movers

Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million

Phil will retain and lead Acuitive Solutions as it continues to expand its expedited shipment routing and multi carrier parcel manifesting solutions for the retail and high fashion industries.

CAAS

Cass Information Systems Acquires AcuAudit From Acuitive Solutions LLC; No Terms Disclosed

Stephens &amp; Co. analyst Terry McEvoy reiterates Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Overweight and maintains $54 price target.

Stephens & Co. Reiterates Overweight on Truist Finl, Maintains $54 Price Target

Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) is up over 13% in the past 24 hours, driven by renewed market enthusiasm after co-founder Charles Hoskinson expressed confidence in <a href="https://www.benzinga.com/money/cardano-price-prediction">the platform's future</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>)</td>
<td>&nbsp;$0.9675</td>
<td>$33.99 billion</td>
<td>+13.7%&nbsp;</td>
<td>&nbsp;+10.9%</td>
</tr>
<tr>
<td>TRON (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/trx/usd">TRX</a>)</td>
<td>&nbsp;$0.2617</td>
<td>$22.6 billion</td>
<td>+3.3%&nbsp;</td>
<td>&nbsp;+3.8%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.40</td>
<td>$138 billion</td>
<td>+12.7%&nbsp;</td>
<td>&nbsp;+9.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto analyst Ali Martinez on Thursday flagged a buy signal on ADA's daily chart, pointing to potential further gains.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The TD Sequential indicator presents a buy signal on the <a href="https://twitter.com/hashtag/Cardano?src=hash&amp;ref_src=twsrc%5Etfw">#Cardano</a> <a href="https://twitter.com/search?q=%24ADA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ADA</a> daily chart! <a href="https://t.co/09w4NLm66S">pic.twitter.com/09w4NLm66S</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1874623896147701842?ref_src=twsrc%5Etfw">January 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Castillo Trading <a href="https://x.com/CastilloTrading/status/1874667321492644306">described</a> Cardano's chart as &#8220;pretty clean,&#8221; highlighting a breakout above resistance. Castillo anticipates further upward movement following a retest of support levels.
Statistics: IntoTheBlock data shows Cardano whale transactions narrowed by 8.2% to $7.5 billion, while daily active addressed inched down by 0.08%. Transactions greater than $100,000 dropped from 709 to 613 in a single day.
Around 63% of Cardano holders remain in profit. Coinglass data shows open interest having spiked 20% in a single day to $747.5 million. Cardano derivatives trading volume surged 129.4%.
Community News: In a post on <a href="https://x.com/IOHK_Charles/status/1873889708218212707">X</a> on Dec. 31, Hoskinson emphasized Cardano's ongoing advancements, including Bitcoin DeFi integration, Midnight (a privacy-focused blockchain), partner chains, DApp upgrades and the enigmatic "fire rises" feature.
In another <a href="https://x.com/IOHK_Charles/status/1874169784918474804">post</a> on Jan. 1, Hoskinson reflected on his decade-long commitment to Cardano, acknowledging past missteps while emphasizing adherence to the roadmap. The blockchain is transitioning into the &#8220;Age of Voltaire,&#8221; which aims to achieve full decentralization and empower the community to govern the network.
Key developments in the Voltaire era include self-sustainability through governance mechanisms like budgeting and constitutional approvals. Hoskinson pledged to oversee these processes to ensure community-driven progress.
Despite past challenges, Hoskinson remains confident in the value of perseverance, hard work, and Cardano&#8217;s potential. The platform's growing capabilities could set the stage for a standout performance in 2025.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42098422/heres-how-much-100-invested-in-cardano-today-could-be-worth-if-ada-hits-new-all-time-highs">Here&#8217;s How Much $100 Invested In Cardano Today Could Be Worth If ADA Hits New All-Time Highs</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$TRX

$USDC

$XRP

Cardano Price Surges 13% On Thursday: What Is Driving ADA Momentum?

BlackRock iShares China Large Cap UCITS ETF USD (Dist)

Comments

ISHARES PLC RESOURCES NL by IShares Plc.

ISHARES PLC RESOURCES NL by IShares Plc. (IHRPF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga